Part,  Chapter, Paragraph

 1   II,     5.  4.  1|   replacement therapy: dialysis or transplantation);~Impotence: On average,
 2   II,     5.  4.  2|       incidence of dialysis and/or transplantation (renal replacement therapy
 3   II,     5.  4.  2|     Prevalence (stock) of dialysis/transplantation (renal replacement therapy)
 4   II,     5.  4.  2|       incidence of dyalisis and/or transplantation is defined as the number
 5   II,     5.  4.  2|         cases with dialysis and/or transplantation (renal replacement therapy)
 6   II,     5.  4.  2|     Prevalence (stock) of dialysis/transplantation per 100.000 diabetic population
 7   II,     5.  4.  2|            all cases with dialysis/transplantation per 100,000 individuals
 8   II,     5.  4.  3|       incidence of dyalisis and/or transplantation. EUCID found a variation
 9   II,     5.  4.  3|     Prevalence (stock) of dialysis/transplantation per 100.000 diabetic population.
10   II,     5.  7.  1|           stage where dialysis and transplantation are needed, second because
11   II,     5.  7.  1|     Pontoriero et al, 2007). Renal transplantation is the most cost-effective
12   II,     5.  7.  1|     imaging abnormalities~• kidney transplantation~2. GFR <60 ml/min/1.73 m2 ,
13   II,     5.  7.  1|            V codes for dialysis or transplantation~5 D if dialysis (HD or PD)~ ~*
14   II,     5.  7.  3|          high as that after kidney transplantation: 60% and 13%, respectively.~
15   II,     5.  7.  5|         the Austrian Dialysis- and Transplantation Registry (OEDTR) shall take
16   II,     5.  7.  5|           average waiting time for transplantation is about 2 years. Accessibility
17   II,     5.  7.  6|          cadaver kidneys for renal transplantation is far below the demand.
18   II,     5. 12.  3|          liver functions and liver transplantationmay also have had some
19   II,     5. 12.  6|          the introduction of liver transplantation.~ ~The impact of the introduction
20   II,     5. 12.  6|    long-term prognosis after liver transplantation and the fact that the procedure
21   II,     5. 12.  6|          of cirrhosis cases, liver transplantation is performed after identification
22   II,     5. 12.  6|           the favourable impact of transplantation on chronic liver disease
23   II,     5. 12.  6|            wider adoption of liver transplantation in the future is likely
24   II,     5. 12.  7|    Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using
25   II,     6.  3.  7|            infection through organ transplantation and blood transfusion has
26   IV,    11.  5.  1|           the past 50 years, organ transplantation has become established worldwide,
27   IV,    11.  5.  1|            use of human organs for transplantation has steadily increased during
28   IV,    11.  5.  1|            the past decades. Organ transplantation is now the most cost-effective
29   IV,    11.  5.  1|            exchanges mean that the transplantation process is carried out by
30   IV,    11.  5.  1|  jurisdictions. Organ donation and transplantation are sensitive and complex
31   IV,    11.  5.  1|        Lithuania).~In a NTO model, transplantation is a complex healthcare
32   IV,    11.  5.  1|          planning all donation and transplantation activities within their
33   IV,    11.  5.  1|        favourable results of organ transplantation, by enlarging the recipient
34   IV,    11.  5.  1|         initially limited to renal transplantation and later expanding to the
35   IV,    11.  5.  1|             heart, lung and tissue transplantation.~ ~Figure 11.10. International
36   IV,    11.  5.  1|      Figures On Organ Donation and Transplantation~ ~Success of transplantation
37   IV,    11.  5.  1|       Transplantation~ ~Success of transplantation indeed depends on several
38   IV,    11.  5.  2|         European Society for Organ Transplantation (ESOT) ( w ~ ~EU National
39   IV,    11.  5.  2|        Registry for Heart and Lung Transplantation: htt Spanish Bone Marrow
40   IV,    11.  5.  3|    European survey on donation and transplantation activities~ ~In 2003 the
41   IV,    11.  5.  3|             2003) related to organ transplantation in the 25 EU Member States
42   IV,    11.  5.  3|      aspects in the field of organ transplantation. The results of this survey
43   IV,    11.  5.  3|                  Authorisation for transplantation procedures~ ~The requirements
44   IV,    11.  5.  3|           organ procurement, organ transplantation (figure 11.12) organ exchange
45   IV,    11.  5.  3|      countries~Figure 11.12. Organ transplantation in different European countries~
46   IV,    11.  5.  3|  guidelines:~ ~Figure 11.18. Organ transplantation procedures.~ ~
47   IV,    11.  5.  4|          face with regard to organ transplantation of humans organs by organized
48   IV,    11.  5.  4|           activity and 5% of liver transplantation. Although living donors
49   IV,    11.  5.  4|           always been critical for transplantation, the donations from living
50   IV,    11.  5.  4|       donation.~Organ donation and transplantation are medical treatments that
51   IV,    11.  5.  4|  professionals and the media about transplantation issues.~Because both positive
52   IV,    11.  5.  4|          organise the donation and transplantation activities.~The different
53   IV,    11.  5.  4|  differences in organ donation and transplantation activity, with some organisational
54   IV,    11.  5.  4|        process from procurement to transplantation should be completed in a
55   IV,    11.  5.  4|          element of organ donation/transplantation systems.~As part of this
56   IV,    11.  5.  4|     process from organ donation to transplantation, whose complexity may make
57   IV,    11.  5.  4|       safety of organ donation and transplantation~ ~Transmission of HIV/AIDS,
58   IV,    11.  5.  4|        fungi and parasites through transplantation, as well as of for different
59   IV,    11.  5.  4|      essential part of solid organ transplantation.~This evaluation must provide
60   IV,    11.  5.  5|            11.5.5. Research in the transplantation field~ ~Current situation
61   IV,    11.  5.  5|       potential impact, related to transplantation medicine both in terms of
62   IV,    11.  5.  5|          implement a new vision of transplantation research requiring a high
63   IV,    11.  5.  5|           the project called TRIE (Transplantation Research Integration across
64   IV,    11.  5.  5|       European research project in transplantation field:~ ~ETPOD is a project
65   IV,    11.  5.  5|   Programmes on Organ Donation and Transplantation):~The Alliance-O consortium
66   IV,    11.  5.  5|          decided to focus on organ transplantation policies and planned to
67   IV,    11.  5.  5|     programmes for improving Organ Transplantation efficiency addressed in
68   IV,    11.  5.  5|        safety and quality of organ transplantation, the evaluation methodology
69   IV,    11.  5.  5|          the organisation of organ transplantation.~Duration: : 3 years.~-
70   IV,    11.  5.  6|       research programmes on organ transplantation in order to maximise the
71   IV,    11.  5.  6|            of cooperation in organ transplantation (SP-CTO). This group prepared
72   IV,    11.  5.  6|            a Steering Committee on Transplantation (CD-PTO) and will continue
73   IV,    11.  5.  6|          to human organ and tissue transplantation dated January 24, 2002.
74   IV,    11.  5.  6|          publications in the organ transplantation field~ ~2005Recom 11 on
75   IV,    11.  5.  6|         the authorisation of organ transplantation facilities~2004Recom )8
76   IV,    11.  5.  6|     document~1997Recom 16 on liver transplantation from living related donors~
77   IV,    11.  5.  6|           problems raised by organ transplantation~ – Organisational and educational
78   IV,    11.  5.  6|       educational aspects of organ transplantation~ – Legislative measures
79   IV,    11.  5.  6|      measures in relation to organ transplantation and to European co-operation~ –
80   IV,    11.  5.  6|            co-operation~1987 Renal transplantation: sense and sensitization
81   IV,    11.  5.  6|           to removal, grafting and transplantation of human substances~ ~·
82   IV,    11.  5.  6|           organs of human origin~ ~Transplantation in general has higher measurable
83   IV,    11.  5.  6|        therapies. Results of organ transplantation are progressively improving
84   IV,    11.  5.  7|    donation and equalise access to transplantation. Since the potential growth
85   IV,    11.  6.  2|           e.g. diabetes, epilepsy, transplantation, leprosy, syphilis, cancerous
86   IV,    11.  6.  4|       disease areas (orthopaedics, transplantation, emergency, neonatal/maternal,
87   IV,    11.  6.  5|     Commission (2003): Human organ~transplantation in Europe: an overview [
88   IV,    11.  6.  5|         research on cell and organ transplantation: towards novel opportunities?
89   IV,    13.  7    |         human origin. Today, organ transplantation has become a common and
90   IV,    13.  7.  3|      cancers in infants, and heart transplantation in children), evaluation
91  Key,   Ap5.  0.  0| trafficking~transfusion~transplant~transplantation~transplanted~transplants~